MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
https://www.nature.com/articles/cgt20176.pdf
Reference33 articles.
1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115–132.
2. Sharma A, Raina V, Lokeshwar N, Deo SV, Shukla NK, Mohanti BK . Phase II study of cisplatin, etoposide and paclitaxel in locally advanced or metastatic adenocarcinoma of gastric/gastroesophageal junction. Indian J Cancer 2006; 43: 16–19.
3. Miles GD, Seiler M, Rodriguez L, Rajagopal G, Bhanot G . Identifying microRNA/mRNA dysregulations in ovarian cancer. BMC Res Notes 2012; 5: 164.
4. Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.
5. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853–858.
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors;Cancer Drug Resistance;2024-02-28
2. Molecular mechanisms of cisplatin resistance in ovarian cancer;Genes & Diseases;2023-08
3. MiR 216b modulates cisplatin resistance and stem cell like features in breast cancer cells by targeting E2F4;Tropical Journal of Pharmaceutical Research;2023-02-18
4. miR-216b-5p promotes late apoptosis/necroptosis in trastuzumab-resistant SK-BR-3 cells;Turkish Journal of Biology;2023-01-01
5. miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer;International Journal of Molecular Sciences;2022-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3